Cargando…
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
BACKGROUND: The clinical course of COVID-19 patients ranges from asymptomatic infection, via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which enable an early prediction of the severity of COVID-19 progression, would be enormously beneficial to guide patient care...
Autores principales: | Hufnagel, Katrin, Fathi, Anahita, Stroh, Nadine, Klein, Marco, Skwirblies, Florian, Girgis, Ramy, Dahlke, Christine, Hoheisel, Jörg D., Lowy, Camille, Schmidt, Ronny, Griesbeck, Anne, Merle, Uta, Addo, Marylyn M., Schröder, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089829/ https://www.ncbi.nlm.nih.gov/pubmed/37041310 http://dx.doi.org/10.1038/s43856-023-00283-z |
Ejemplares similares
-
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019) -
Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
por: Fathi, Anahita, et al.
Publicado: (2021) -
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter
por: Miao, Beiping, et al.
Publicado: (2021) -
Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
por: Shamsrizi, Parichehr, et al.
Publicado: (2021) -
Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
por: Badbaran, Anita, et al.
Publicado: (2021)